Clinical Trials in Seattle

Showing 3821-3840 of 9,312 trials

Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

NCT01267812

RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Giving bortezomib together with rituximab may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving bortezomib and rituximab together works in treating patients with mantle cell lymphoma who have previously undergone stem cell transplantation

Contiguous Stage II Mantle Cell LymphomaNoncontiguous Stage II Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+3 more

City of Hope Medical Center23 participantsStarted Oct 2011

Duarte, California, United States • Seattle, Washington, United States

COMPLETEDNA< 1 mile

Evaluation Of New Onset Postoperative Atrial Fibrillation

NCT01247974

This is a multi-center, prospective, randomized and controlled clinical trial comparing the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation by circumferentially reconstructing the normal pericardial anatomy following isolated, first-time, CABG procedures compared to subjects that do not undergo pericardial closure. This trial will be conducted at up to 20 clinical sites in the U.S.

Atrial Fibrillation New Onset

Elutia Inc.439 participantsStarted Dec 2010

Birmingham, Alabama, United States • Dothan, Alabama, United States • Mobile, Alabama, United States +13 more locations

Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

Evaluation Of New Onset Postoperative Atrial Fibrillation

Find Trials by Condition in Seattle

Integrating Care After Exacerbation of COPD

Extended Cold Stored Apheresis Platelets in Cardiac Surgery Patients

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients

Clinical Trial Proximal Caries Infiltration and Detection

Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity